ITERUM THERAPEUTICS PLC (ITRM) Stock Cash Flow
NASDAQ:ITRM - Nasdaq - IE000TTOOBX0 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.37M | -44.43M | -91.56M | -52.01M | -103.13M | |||
| Depreciation Amortization | 1.75M | 1.80M | 2.10M | 160.00K | 150.00K | |||
| Change In Working Capital | 2.76M | 2.31M | -440.00K | -24.56M | 17.90M | |||
| Interest Paid | 0.00 | 20.00K | 420.00K | 1.00M | 1.40M | |||
| Taxes Paid | 401.00K | 820.00K | 440.00K | 120.00K | 410.00K | |||
| Other non cash items | -5.47M | 21.85M | 74.06M | 21.87M | 3.16M | |||
| OPERATING CASH FLOW | -39.33M | -18.47M | -15.84M | -54.53M | -81.92M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -13.00K | -60.00K | -60.00K | -10.00K | -20.00K | |||
| Other Investing Activity | 23.35M | 14.02M | -54.53M | N/A | 40.13M | |||
| INVESTING CASH FLOW | 23.34M | 13.96M | -54.60M | -10.00K | 40.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -2.25M | -6.52M | -5.49M | -1.03M | |||
| Stock Issued/Repurchased | 1.03M | 430.00K | 89.64M | 69.96M | 3.10M | |||
| FINANCING CASH FLOW | 1.03M | -1.82M | 83.13M | 64.48M | 2.06M | |||
| Exchange Rate Effect | -61.00K | -50.00K | 0.00 | -10.00K | -20.00K | |||
| CHANGE IN CASH | -15.02M | -6.38M | 12.69M | 9.93M | -39.78M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -39.33M | -18.47M | -15.84M | -54.53M | -81.92M | |||
| Capital Expenditure | -13.00K | -60.00K | -60.00K | -10.00K | -20.00K | |||
| FREE CASH FLOW | -39.34M | -18.53M | -15.90M | -54.54M | -81.94M | |||
All data in USD